Data is not available at this time.
Macromill, Inc. operates as a specialized provider of marketing research and digital marketing solutions, leveraging advanced neuroresearch techniques to analyze consumer behavior beyond traditional surveys. The company's core offerings include Internet and offline research, digital marketing analytics, and data-driven advertising services, positioning it at the intersection of neuroscience and marketing intelligence. Its proprietary tools, such as Movie Karte for video ad effectiveness and Macromill Ads for digital campaign optimization, differentiate it in the competitive advertising agency sector. With a strong foothold in Japan and collaborations like its partnership with Sumitomo Mitsui Card Co., Macromill combines scientific rigor with scalable digital solutions to serve global clients. The company’s focus on high-value, data-centric services allows it to cater to industries requiring deep consumer insights, including healthcare and e-commerce. Its ability to integrate neuroresearch with traditional and digital marketing methodologies reinforces its niche leadership and adaptability in a rapidly evolving market.
Macromill reported revenue of ¥43.9 billion for FY 2024, with net income of ¥2.3 billion, reflecting a net margin of approximately 5.2%. Operating cash flow stood at ¥8.3 billion, supported by efficient working capital management. Capital expenditures were modest at ¥307 million, indicating a capital-light model focused on scalable digital services rather than heavy infrastructure investments.
The company’s diluted EPS of ¥59.86 underscores its earnings capability, though its beta of 0.395 suggests lower volatility relative to the market. With a debt-to-equity ratio influenced by ¥33.1 billion in total debt against ¥10.4 billion in cash, Macromill’s capital structure leans moderately leveraged, but its stable cash flows mitigate refinancing risks.
Macromill maintains a liquidity buffer with ¥10.4 billion in cash and equivalents, though its total debt of ¥33.1 billion warrants monitoring. The balance sheet reflects a focus on growth financing, with manageable leverage given its consistent operating cash generation. The absence of significant capex demands supports financial flexibility.
The company’s growth is tied to demand for data-driven marketing solutions, with dividends of ¥15 per share signaling a commitment to shareholder returns. Its market cap of ¥48.9 billion implies investor confidence in its niche positioning, though top-line expansion will depend on adoption of its neuroresearch and digital ad tools in new markets.
Trading at a market cap of ¥48.9 billion, Macromill’s valuation reflects its specialized capabilities in neuroresearch and digital marketing. The low beta suggests defensive positioning, while the P/E ratio derived from its EPS indicates moderate growth expectations. Its collaboration-driven model may unlock further upside if partnerships expand globally.
Macromill’s integration of neuroscience with marketing analytics provides a durable edge in an increasingly data-centric industry. Its partnerships and scalable digital offerings position it well for cross-border growth, though competition from larger ad networks remains a challenge. The outlook hinges on leveraging its technological differentiation while maintaining profitability in a fragmented sector.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |